Annual report pursuant to Section 13 and 15(d)

ACQUISITIONS - Narrative (Details)

v3.24.1
ACQUISITIONS - Narrative (Details)
 1 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
Jul. 31, 2022
USD ($)
shares
Apr. 30, 2022
USD ($)
ft²
dispensary
$ / shares
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
ft²
dispensary
$ / shares
shares
Jul. 31, 2021
USD ($)
ft²
Apr. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2023
USD ($)
Jul. 31, 2021
a
Business Acquisition [Line Items]                        
Other liabilities - non-current                 $ 1,395,000   $ 0  
Acquisition related costs                 1,204,000 $ 350,000    
Contributed revenues                 28,912,000 15,107,000    
Contributed net (loss) income                 (43,603,000) $ (1,120,000)    
Acquisition Milestone Accrual                        
Business Acquisition [Line Items]                        
Contingent consideration liabilities - current portion                 0   4,167,000  
Thirty-Month Anniversary Contingent Consideration                        
Business Acquisition [Line Items]                        
Contingent consideration liabilities - current portion                 3,398,000   817,000  
OhiGrow                        
Business Acquisition [Line Items]                        
Area of real estate property (in sq ft)           10,000           1.35
Consideration paid in cash, as adjusted for working capital adjustments           $ 4,949,000            
Grover Beach                        
Business Acquisition [Line Items]                        
Consideration paid in cash, as adjusted for working capital adjustments               $ 3,592,000        
Equity acquired 22.00%             78.00%        
Equity interest issued and issuable (in shares) | shares               49,348        
Equity issued, price per share (in dollars per share) | $ / shares               $ 7.46        
Rights to remaining equity               $ 1        
Nature's Remedy Three-Year Note | Unsecured Debt                        
Business Acquisition [Line Items]                        
Debt instrument term 3 years       3 years              
Debt instrument principal amount         $ 11,500,000              
Nature's Remedy Five-Year Note                        
Business Acquisition [Line Items]                        
Debt instrument term         5 years              
Nature's Remedy Five-Year Note | Unsecured Debt                        
Business Acquisition [Line Items]                        
Debt instrument principal amount         $ 5,000,000              
NuLeaf                        
Business Acquisition [Line Items]                        
Equity interests acquired     100.00%                  
Consideration paid in cash, net of working capital adjustments     $ 14,918,000                  
Equity issued (in shares) | shares     4,662,384                  
Equity issued, price per share (in dollars per share) | $ / shares     $ 2.91                  
Debt instrument term   5 years 5 years                  
Consideration payable in cash (customary hold back liability)     $ 932,000                  
Contingent liability     10,000,000                  
Contingent liability, cash     3,000,000                  
Contingent liability, additional debt     3,000,000                  
Payment for contingent consideration liability   $ 3,000,000                    
Payment for contingent consideration liability, net   $ 2,657,000                    
Equity interest issued to settle contingent liability (in shares) | shares   888,880                    
Equity interest issued to settle contingent liability   $ 1,529,000                    
Consideration paid in promissory notes (fair value)     12,860,000                  
Contingent consideration liabilities - current portion     7,989,000                  
NuLeaf | Nuleaf Unsecured Promissory Notes | Unsecured Debt                        
Business Acquisition [Line Items]                        
Debt instrument principal amount     15,750,000                  
Senior notes, fair value     $ 12,860,000                  
NuLeaf | Las Vegas, Nevada                        
Business Acquisition [Line Items]                        
Number of retail dispensaries | dispensary     2                  
NuLeaf | Las Vegas Boulevard, Nevada                        
Business Acquisition [Line Items]                        
Number of retail dispensaries | dispensary     1                  
NuLeaf | Sparks, Nevada                        
Business Acquisition [Line Items]                        
Area of real estate property (in sq ft) | ft²     27,000                  
NuLeaf | Reno, Nevada                        
Business Acquisition [Line Items]                        
Area of real estate property (in sq ft) | ft²     13,000                  
Apothecarium                        
Business Acquisition [Line Items]                        
Equity interests acquired       100.00%                
Consideration paid in cash, net of working capital adjustments       $ 6,703,000                
Equity issued (in shares) | shares       527,704                
Equity issued, price per share (in dollars per share) | $ / shares       $ 3.02                
Debt instrument term       5 years                
Consideration payable in cash (customary hold back liability)       $ 0                
Consideration paid in promissory notes (fair value)       9,853,000                
Consideration paid in promissory notes (fair value)       6,922,000                
Contingent consideration liabilities - current portion       $ 0                
Nature’s Remedy                        
Business Acquisition [Line Items]                        
Equity interests acquired         100.00%              
Number of retail dispensaries | dispensary         2              
Area of real estate property (in sq ft) | ft²         50,000              
Equity issued (in shares) | shares         8,700,000              
Equity issued, price per share (in dollars per share) | $ / shares         $ 4.10              
Contingent liability         $ 8,223,000       4,793,000      
Payment for contingent consideration liability   $ 5,000,000                    
Consideration paid in promissory notes (fair value)         15,345,000              
Contingent consideration, equity interest issued and issuable         5,000,000              
Contingent consideration period 13 months                      
Minimum contingent consideration         0              
Maximum contingent consideration         10,800,000              
Contingent consideration, monthly earnout         278,000              
Contingent consideration, earnout ratio         $ 1,667,000              
Contingent consideration liabilities - current portion                 3,398,000      
Other liabilities - non-current                 $ 1,395,000      
Nature’s Remedy | Acquisition Milestone Accrual                        
Business Acquisition [Line Items]                        
Contingent consideration liabilities - current portion                     4,167,000  
Nature’s Remedy | Thirty-Month Anniversary Contingent Consideration                        
Business Acquisition [Line Items]                        
Contingent consideration liabilities - current portion                     $ 817,000  
Nature’s Remedy | First Milestone Period                        
Business Acquisition [Line Items]                        
Contingent consideration period         12 months              
Nature’s Remedy | Monthly Milestone Period One                        
Business Acquisition [Line Items]                        
Contingent consideration period 18 months                      
Nature’s Remedy | Monthly Milestone Period Two                        
Business Acquisition [Line Items]                        
Contingent consideration period 24 months                      
Nature’s Remedy | Monthly Milestone Period Three                        
Business Acquisition [Line Items]                        
Contingent consideration period 30 months                      
Nature’s Remedy | Nature's Remedy Three-Year Note                        
Business Acquisition [Line Items]                        
Debt instrument term 3 years       3 years              
Contingent liability, additional debt $ 5,000,000       $ 5,000,000              
Consideration paid in promissory notes (fair value)         $ 11,500,000              
Maximum contingent consideration, net $ 4,708,000                      
Nature’s Remedy | Nature's Remedy Five-Year Note                        
Business Acquisition [Line Items]                        
Debt instrument term         5 years              
Consideration paid in promissory notes (fair value)         $ 5,000,000              
OSD                        
Business Acquisition [Line Items]                        
Equity interests acquired             100.00%          
Consideration paid in promissory notes (fair value)             $ 3,100,000          
Consideration paid in promissory notes (fair value)             $ 2,429,000